RE:RE:RE:RE:RE:RE:cost of bg pill trial at Montreal heart Institute guess behind schedule again......
May 28/20 - Research and Development of $503,000 in Q1 2020 vs $801,000 in 2019. This decreased investment was partly due to a slowdown of recruitment of patients for the beta glucan trial during the pandemic crisis.
lscfa wrote: Feb 20, 2020 -
Patient enrollment expected to be completed by January 2021 – The 18 to 24-month study will enroll approximately 264 subjects who cannot tolerate high doses of current treatments.
Ciao wrote: The BG pill would be marketed as a nutraceuitical and not a drug, so I don't think they have years to go. If they spent $1M so far, I think that's fine. They are sitll in great financial shape.
If you look at AMARIN, they had a market cap of $350M, and when they when on the hype fora fish oil pill for reducing LDL, they peaked with at a market cap of $8B+. So let CZO spend a few more million if needed to get to the prize, I believe most of us have no issue with that.
lscfa wrote: The point is CZO has probably spent over $1 million already on the BG pill study and still have years to go.
westcoast1000 wrote: lscfa,
What they spent in the past is not relevant to what that particular trial will cost.
There just isn't that much cost involved in setting up the trial, getting the subjects, giving a pill, monitoring, and blood tests.
Even if they paid for two months of the investigator's salary plus overhead to design and oversee the trial, that would only add maybe $50 K.